| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 175 (4), 998-1013. e20, 2018 | 1433 | 2018 |
| Resistance to checkpoint blockade therapy through inactivation of antigen presentation M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ... Nature communications 8 (1), 1136, 2017 | 825 | 2017 |
| Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections DM Tobin, FJ Roca, SF Oh, R McFarland, TW Vickery, JP Ray, DC Ko, ... Cell 148 (3), 434-446, 2012 | 651 | 2012 |
| The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans DM Tobin, JC Vary, JP Ray, GS Walsh, SJ Dunstan, ND Bang, DA Hagge, ... Cell 140 (5), 717-730, 2010 | 610 | 2010 |
| Genome-wide enhancer maps link risk variants to disease genes J Nasser, DT Bergman, CP Fulco, P Guckelberger, BR Doughty, ... Nature 593 (7858), 238-243, 2021 | 394 | 2021 |
| The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells JP Ray, MM Staron, JA Shyer, PC Ho, HD Marshall, SM Gray, BJ Laidlaw, ... Immunity 43 (4), 690-702, 2015 | 305 | 2015 |
| Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells JP Ray, HD Marshall, BJ Laidlaw, MM Staron, SM Kaech, J Craft Immunity 40 (3), 367-377, 2014 | 251 | 2014 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 176 (1), 404, 2019 | 214 | 2019 |
| Positional specificity of different transcription factor classes within enhancers SR Grossman, J Engreitz, JP Ray, TH Nguyen, N Hacohen, ES Lander Proceedings of the National Academy of Sciences 115 (30), E7222-E7230, 2018 | 91 | 2018 |
| The transforming growth factor beta signaling pathway is critical for the formation of CD4 T follicular helper cells and isotype-switched antibody responses in the lung mucosa HD Marshall, JP Ray, BJ Laidlaw, N Zhang, D Gawande, MM Staron, ... Elife 4, e04851, 2015 | 74 | 2015 |
| An Enzyme That Inactivates the Inflammatory Mediator Leukotriene B4 Restricts Mycobacterial Infection DM Tobin, FJ Roca, JP Ray, DC Ko, L Ramakrishnan PloS one 8 (7), e67828, 2013 | 64 | 2013 |
| Global discovery of lupus genetic risk variant allelic enhancer activity X Lu, X Chen, C Forney, O Donmez, D Miller, S Parameswaran, T Hong, ... Nature communications 12 (1), 1611, 2021 | 47 | 2021 |
| Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features JP Ray, CG de Boer, CP Fulco, CA Lareau, M Kanai, JC Ulirsch, ... Nature communications 11 (1), 1237, 2020 | 44 | 2020 |
| Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells K Mouri, MH Guo, CG de Boer, MM Lissner, IA Harten, GA Newby, ... Nature genetics 54 (5), 603-612, 2022 | 33 | 2022 |
| MAUDE: inferring expression changes in sorting-based CRISPR screens CG de Boer, JP Ray, N Hacohen, A Regev Genome Biology 21 (1), 134, 2020 | 30 | 2020 |
| PTENtiating autoimmunity through Treg cell deregulation JP Ray, J Craft Nature immunology 16 (2), 139-140, 2015 | 15 | 2015 |
| Genome-wide maps of enhancer regulation connect risk variants to disease genes J Nasser, DT Bergman, CP Fulco, P Guckelberger, BR Doughty, ... bioRxiv, 2020.09. 01.278093, 2020 | 13 | 2020 |
| Systematic identification of genomic elements that regulate FCGR2A expression and harbor variants linked with autoimmune disease J Dahlqvist, CP Fulco, JP Ray, T Liechti, CG de Boer, DJ Lieb, ... Human molecular genetics 31 (12), 1946-1961, 2022 | 9 | 2022 |
| Genome-wide discovery of SLE genetic risk variant allelic enhancer activity X Lu, X Chen, C Forney, O Donmez, D Miller, S Parameswaran, T Hong, ... Biorxiv, 2020.01. 20.906701, 2020 | 4 | 2020 |
| Impact of autoimmune risk alleles on the immune system JP Ray, N Hacohen Genome Medicine 7, 1-3, 2015 | 4 | 2015 |
